Eli Lilly's new Alzheimer's treatment could 'lift' drug market

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.Investor's Business Daily• Biden administration seeks to wipe consumer medical debt off most credit reports with proposed rule The Biden administration is pushing to prevent medical debt from being considered in most decisions made over whether someone qualifies to rent an apartment, buy a car or take on a mortgage. The …